Annual SG&A:
$0.00-$117.53M(-100.00%)Summary
- As of today, RYTM annual SG&A is $0.00, with the most recent change of -$117.53 million (-100.00%) on December 31, 2024.
- During the last 3 years, RYTM annual SG&A has fallen by -$68.49 million (-100.00%).
- RYTM annual SG&A is now -100.00% below its all-time high of $117.53 million, reached on December 31, 2023.
Performance
RYTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$39.09M(-100.00%)Summary
- As of today, RYTM quarterly SG&A is $0.00, with the most recent change of -$39.09 million (-100.00%) on June 30, 2025.
- Over the past year, RYTM quarterly SG&A has dropped by -$36.41 million (-100.00%).
- RYTM quarterly SG&A is now -100.00% below its all-time high of $39.09 million, reached on March 31, 2025.
Performance
RYTM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.72B-$183.10M(-4.03%)Summary
- As of today, RYTM TTM SG&A is -$4.72 billion, with the most recent change of -$183.10 million (-4.03%) on June 30, 2025.
- Over the past year, RYTM TTM SG&A has dropped by -$4.86 billion (-3634.45%).
- RYTM TTM SG&A is now -9222.20% below its all-time high of -$50.67 million.
Performance
RYTM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RYTM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | -3634.4% |
| 3Y3 Years | -100.0% | -100.0% | -5840.9% |
| 5Y5 Years | -100.0% | -100.0% | -10000.0% |
RYTM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | -96.4% | at low |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | -214.9% | at low |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | -9222.2% | at low |
RYTM Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $74.46M(-32.8%) |
| Mar 2025 | - | $39.09M(>+9900.0%) | $110.88M(+4.4%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $106.17M(-23.4%) |
| Sep 2024 | - | $35.38M(-2.9%) | $138.55M(+3.7%) |
| Jun 2024 | - | $36.41M(+5.9%) | $133.65M(+5.0%) |
| Mar 2024 | - | $34.38M(+6.2%) | $127.28M(+8.3%) |
| Dec 2023 | $117.53M(+27.7%) | $32.37M(+6.2%) | $117.53M(+5.4%) |
| Sep 2023 | - | $30.48M(+1.4%) | $111.47M(+8.3%) |
| Jun 2023 | - | $30.05M(+22.0%) | $102.94M(+8.1%) |
| Mar 2023 | - | $24.63M(-6.4%) | $95.22M(+3.5%) |
| Dec 2022 | $92.03M(+34.4%) | $26.32M(+20.0%) | $92.03M(+6.1%) |
| Sep 2022 | - | $21.94M(-1.7%) | $86.71M(+5.4%) |
| Jun 2022 | - | $22.33M(+4.1%) | $82.28M(+9.1%) |
| Mar 2022 | - | $21.45M(+2.2%) | $75.42M(+10.1%) |
| Dec 2021 | $68.49M(+48.5%) | $21.00M(+19.9%) | $68.49M(+13.0%) |
| Sep 2021 | - | $17.51M(+13.2%) | $60.61M(+11.4%) |
| Jun 2021 | - | $15.46M(+6.5%) | $54.39M(+13.7%) |
| Mar 2021 | - | $14.52M(+10.7%) | $47.85M(+3.7%) |
| Dec 2020 | $46.13M(+26.2%) | $13.12M(+16.2%) | $46.13M(+8.7%) |
| Sep 2020 | - | $11.29M(+26.5%) | $42.42M(+1.8%) |
| Jun 2020 | - | $8.92M(-30.3%) | $41.67M(+0.2%) |
| Mar 2020 | - | $12.80M(+35.9%) | $41.59M(+13.8%) |
| Dec 2019 | $36.55M | $9.41M(-10.6%) | $36.55M(+2.9%) |
| Sep 2019 | - | $10.54M(+19.2%) | $35.52M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $8.84M(+13.9%) | $33.53M(+7.7%) |
| Mar 2019 | - | $7.76M(-7.5%) | $31.12M(+10.8%) |
| Dec 2018 | $28.08M(+195.0%) | $8.39M(-1.8%) | $28.08M(+16.9%) |
| Sep 2018 | - | $8.54M(+32.7%) | $24.02M(+35.0%) |
| Jun 2018 | - | $6.44M(+36.5%) | $17.80M(+39.9%) |
| Mar 2018 | - | $4.71M(+8.9%) | $12.72M(+33.6%) |
| Dec 2017 | $9.52M(+50.8%) | $4.33M(+87.0%) | $9.52M(+83.5%) |
| Sep 2017 | - | $2.31M(+70.6%) | $5.19M(+80.6%) |
| Jun 2017 | - | $1.36M(-10.5%) | $2.87M(+9.3%) |
| Mar 2017 | - | $1.52M(+36.2%) | $2.63M(-52.5%) |
| Dec 2016 | $6.31M(+84.3%) | - | - |
| Jun 2016 | - | $1.11M(-24.4%) | $5.53M(+25.2%) |
| Mar 2016 | - | $1.47M(-27.3%) | $4.42M(+49.9%) |
| Dec 2015 | $3.42M(+182.4%) | - | - |
| Dec 2015 | - | $2.02M(+119.6%) | $2.95M(+176.7%) |
| Sep 2015 | - | $922.00K(+544.8%) | $1.06M(-45.5%) |
| Dec 2014 | $1.21M(-64.7%) | $143.00K(-53.4%) | $1.95M(+7.9%) |
| Sep 2014 | - | $307.00K(-67.4%) | $1.81M(+20.4%) |
| Jun 2014 | - | $941.00K(+67.4%) | $1.50M(-6.6%) |
| Mar 2014 | - | $562.00K(-46.3%) | $1.61M(-8.2%) |
| Dec 2013 | $3.43M(+39.6%) | - | - |
| Jun 2013 | - | $1.05M(+48.3%) | $1.75M(+148.3%) |
| Mar 2013 | - | $706.00K | $706.00K |
| Dec 2012 | $2.46M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of RYTM is $0.00
What is the all-time high annual SG&A for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual SG&A is $117.53M
What is Rhythm Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, RYTM annual SG&A has changed by -$117.53M (-100.00%)
What is Rhythm Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of RYTM is $0.00
What is the all-time high quarterly SG&A for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly SG&A is $39.09M
What is Rhythm Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, RYTM quarterly SG&A has changed by -$36.41M (-100.00%)
What is Rhythm Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of RYTM is -$4.72B
What is the all-time high TTM SG&A for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM SG&A is -$50.67M
What is Rhythm Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, RYTM TTM SG&A has changed by -$4.86B (-3634.45%)